[1]
Akter, S. et al. 2026. Progression free survival by the treatment with Cabozatinib in a case of BRAF mutated Radioiodine refractory recurrent metastatic Papillary Carcinoma Thyroid. Bangladesh Journal of Otorhinolaryngology. 31, 2 (Apr. 2026), 86–94. DOI:https://doi.org/10.3329/bjo.v31i2.89000.